CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

An outpatient case study of Cyaplex F: mitigated adverse effects associated with Imatinib

Cyaplex F 를 적용한 외래환자 증례보고: Imatinib 의 부작용 완화

  • Received : 2023.09.27
  • Accepted : 2023.09.27
  • Published : 2023.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: A case of reducing adverse effects associated with imatinib using Cyaplex F. Methods: The 52-year-old female with past medical history of stage 1 triple-positive breast cancer 10 years ago, and current metastatic melanoma has been complaining adverse effects after imatinib was started. Results: After OCNT was initiated, the patient's headache and muscle pain have been much tolerable and her AST/CPK levels were returned close to her baseline. Conclusion: OCNT may reduce side effects caused by Imatinib and help patient to stay with the current chemotherapy regimen.

Keywords

References

  1. Waks, A. G. & Winer, E. P. J. J. Breast cancer treatment: a review. 321, 288-300 (2019).
  2. Yager, J. D. & Davidson, N. E. J. N. E. J. o. M. Estrogen carcinogenesis in breast cancer. 354, 270-282 (2006).
  3. Ciarletta, P., Foret, L. & Ben Amar, M. J. J. o. t. R. S. I. The radial growth phase of malignant melanoma: multi-phase modelling, numerical simulations and linear stability analysis. 8, 345-368 (2011).
  4. Syn, N. L., Teng, M. W., Mok, T. S. & Soo, R. A. J. T. L. O. De-novo and acquired resistance to immune checkpoint targeting. 18, e731-e741 (2017).
  5. Choi, E., Lee, J., Shin, S. & Mar, W. J. J. A. P. The comparison of histological effects of musk containing and civet containing WooHwangChungSimWon on the cerebral ischemia. 8, 255-261 (2000).
  6. Green, K. N., Crapser, J. D. & Hohsfield, L. A. J. T. i. i. To kill a microglia: a case for CSF1R inhibitors. 41, 771-784 (2020).
  7. Mun, S. H., Park, P. S. U., Park-Min, K.-H. J. E. & medicine, m. The M-CSF receptor in osteoclasts and beyond. 52, 1239-1254 (2020).
  8. Yang, G., Nowsheen, S., Aziz, K., Georgakilas, A. G. J. P. & therapeutics. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs. 139, 392-404 (2013).
  9. Breyer-Pfaff, U. J. D. m. r. The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man. 36, 723-746 (2004).
  10. Wang, B. et al. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. 41, 573-643 (2009).
  11. Anderson, B. M., Ma, D. W. J. L. i. h. & Disease. Are all n-3 polyunsaturated fatty acids created equal? 8, 1-20 (2009).
  12. Mori, N., Nakasone, K., Tomimori, K. & Ishikawa, C. J. W. j. o. g. W. Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection. 18, 2225 (2012).
  13. Toufektsian, M.-C. et al. Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury. 138, 747-752 (2008).
  14. Kedzierska, M. et al. Effects of the commercial extract of aronia on oxidative stress in blood platelets isolated from breast cancer patients after the surgery and various phases of the chemotherapy. 83, 310-317 (2012).
  15. Wang, H. et al. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. 62, 294-296 (1999).
  16. Kamei, H. et al. Suppression of tumor cell growth by anthocyanins in vitro. 13, 590-594 (1995).